Current Trends in Prevalence and Role of Long Noncoding RNA and Gene Fusion in Prostate Cancer: An Overview

Current Trends in Prevalence and Role of Long Noncoding RNA and Gene Fusion in Prostate Cancer: An Overview

Objectives The aim of this study is to analyze the current scenario in the diagnostic modalities for prostate cancer. Materials and Methods We searched PubMed, Google Scholar, and ResearchGate for relevant data. Articles published in the last 10 years were taken into consideration. The ro...

Full description

Bibliographic Details
Main Authors:	Arun Sinha, Praveen Sharma, Kamla Kant Shukla, Prasenjit Mitra, Sanjeev Misra
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-05-01
Series:	Annals of the National Academy of Medical Sciences (India)
Subjects:	long noncoding rna gene fusion products prostate-specific antigen mirna tmprss2:erg
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1729780

Similar Items

Detection of tmprss2-erg and tmprss2-egr1 gene fusion in prostate cancer from a Chinese population
by: Changqing Xu, et al.
Published: (2020-12-01)

Predictive significance of TMRPSS2-ERG fusion in prostate cancer: a meta-analysis
by: Chunjiao Song, et al.
Published: (2018-11-01)

Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers
by: Francesca Giunchi, et al.
Published: (2020-12-01)

Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature
by: Yawei Li, et al.
Published: (2024-02-01)

Molecular Characterization of TMPRSS2-ERG Gene Fusion in the NCI-H660 Prostate Cancer Cell Line: A New Perspective for an Old Model
by: Kirsten D. Mertz, et al.
Published: (2007-03-01)

Chimeric RNA Design Principles for RNA-Mediated Gene Fusion
by: Sachin Kumar Gupta, et al.
Published: (2022-03-01)

Differential Effect of Non-Steroidal Anti-Inflammatory Drugs Aspirin and Naproxen against <i>TMPRSS2-ERG</i> (Fusion)-Driven and Non-Fusion-Driven Prostate Cancer
by: Komal Raina, et al.
Published: (2023-10-01)

TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas, Paired HGPIN Lesions
by: Nuno Cerveira, et al.
Published: (2006-10-01)

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer
by: Kluth M, et al.
Published: (2018-11-01)

Prevalence and clinical application of TMPRSS2-ERG fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review
by: De-Pei Kong, et al.
Published: (2020-01-01)

<it>TMPRSS2-ERG </it>-specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
by: Brase Jan C, et al.
Published: (2011-12-01)

Profile of chimeric RNAs and TMPRSS2-ERG e2e4 isoform in neuroendocrine prostate cancer
by: Qiong Wang, et al.
Published: (2022-09-01)

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer
by: Massimo Lazzeri, et al.
Published: (2022-09-01)

ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor
by: Zineb Mounir, et al.
Published: (2016-05-01)

The Genetic Complexity of Prostate Cancer
by: Eva Compérat, et al.
Published: (2020-11-01)

Analysis of Aurora kinases genes expression points on their distinct roles in prostate cancer development
by: O. Mankovska, et al.
Published: (2019-12-01)

SNW1 is a prognostic biomarker in prostate cancer
by: Doris Höflmayer, et al.
Published: (2019-05-01)

PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis
by: Jack A. Schalken, et al.
Published: (2010-07-01)

PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
by: Warli SM, et al.
Published: (2023-05-01)

SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo
by: Carlos D. Cruz-Hernández, et al.
Published: (2020-07-01)

Oligometastatic Squamous Cell Transformation From Metastatic Prostate Adenocarcinoma Treated With Systemic and Focal Therapy: A Case Report
by: Karen Autio, et al.
Published: (2022-08-01)

The Expression of Proto-Oncogene <i>ETS-Related Gene</i> (<i>ERG</i>) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer
by: Ealia Khosh Kish, et al.
Published: (2022-04-01)

Differentially methylated CpG sites associated with the high-risk group of prostate cancer
by: Kobelyatskaya Anastasiya, et al.
Published: (2020-12-01)

<i>ALDH3A2</i>, <i>ODF2</i>, <i>QSOX2</i>, and MicroRNA-503-5p Expression to Forecast Recurrence in <i>TMPRSS2-ERG</i>-Positive Prostate Cancer
by: Anastasiya A. Kobelyatskaya, et al.
Published: (2022-10-01)

Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype
by: Anastasiya A. Kobelyatskaya, et al.
Published: (2023-05-01)

Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing
by: Elena Fountzilas, et al.
Published: (2023-07-01)

No differences in miRNA expression in the stroma of ERG+ and ERG– prostate cancers
by: Gracjan Wątor, et al.
Published: (2024-01-01)

Fusion sequencing via terminator‐assisted synthesis (FTAS‐seq) identifies TMPRSS2 fusion partners in prostate cancer
by: Ugnė Drazdauskienė, et al.
Published: (2023-06-01)

Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity
by: Ying Z. Mazzu, et al.
Published: (2022-07-01)

Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate Cancer
by: Elena A. Pudova, et al.
Published: (2019-08-01)

Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with Rearrangement
by: Maisa Yoshimoto, et al.
Published: (2006-06-01)

Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
by: Anastasiya A. Kobelyatskaya, et al.
Published: (2021-06-01)

Long noncoding RNAs in prostate cancer: overview and clinical implications
by: Bhavna Malik, et al.
Published: (2016-01-01)

Hyperglycemia Promotes TMPRSS2-ERG Gene Fusion in Prostate Cancer Cells via Upregulating Insulin-Like Growth Factor-Binding Protein-2
by: Jeff M. P. Holly, et al.
Published: (2017-11-01)

Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer
by: Vipulkumar Dadhania, et al.
Published: (2022-05-01)

MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery
by: Binod Kumar, et al.
Published: (2016-01-01)

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status
by: Caterina Mancarella, et al.
Published: (2017-05-01)

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
by: Louie Semaan, et al.
Published: (2019-10-01)

BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
by: Xiangyi Li, et al.
Published: (2018-01-01)

Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer
by: Francesca Lorenzin, et al.
Published: (2022-02-01)